Sign In
Buy BIB
$83.72
+1.06 (+1.29%)
At Close: Jun 15, 2026
Dems attack Trump over stalled efforts to lower drug prices
02:32pm, Friday, 21'st Feb 2020
High drug prices will, again, be a key issue in the 2020 Presidential campaign considering that President Trump has made scant progress on the matter despite much rhetoric.White House press secretary
Drugmakers getting creative over ways to pay for pricey meds
05:16pm, Monday, 13'th Jan 2020
Faced with pushback from multiple fronts over high drug prices, biopharmaceutical firms are experimenting with new ways to get paid for their priciest offerings, mostly biologics, in a report from the
California mulling private-label generics to address high drug costs
03:05pm, Thursday, 09'th Jan 2020
The new budget proposed by California Governor Gavin Newsom includes a plan to allow the state to contract with generic drug makers to provide medicines to all Californians. He believes that the gover
3 Top Drug Stocks to Own In 2020
03:44pm, Friday, 03'rd Jan 2020
Broadly speaking, drug stocks have been some of the strongest performing names in the latter part of 2019.Since October 2019, the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB) has rallied from a low o
The Science Of Biotech Investing With Bhavneesh Sharma (Podcast)
12:00am, Monday, 08'th Jul 2019BIB Versus LABU: Comparing Leveraged Biotech ETFs
02:50pm, Tuesday, 25'th Jun 2019
Read a comparison of BIB and LABU and a description of the characteristics and historical performance of these leveraged biotech ETFs.
